Apellis Shares Drop 13% Due to Wider-Than-Expected Q3 Loss and Revenue Miss
Daily NewsWALTHAM, Mass. - Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares fell by 13.48% following the announcement of its third-quarter results, which were below analy...
Read More